💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Lipocine Inc. (LPCN)
« Back to company indexLPCN Chatter Timeline
Stock Ticker for LPCN
Most Active Tweeters for LPCN
| User | Tweets |
|---|---|
| @Tickeron | 6 |
| @ahighelevation | 2 |
| @insidersanalyt1 | 1 |
| @pennystocksusa | 1 |
| @ZacksSmallCap | 1 |
Recent Tweets for LPCN
 |
@Tickeron $LPCN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/ytI7oF3t4n December 2nd 2021, 1:12am |
 |
@ZacksSmallCap $LPCN Commercialization Partner Secured for the US #biopharma #TRT - https://t.co/lpry2IUEqS https://t.co/v6lyEEm6DQ December 1st 2021, 9:12pm |
 |
@ahighelevation $LPCN Now Partnered for US Commercialization #biotech #biopharma - https://t.co/JV0HxNvdhF https://t.co/G5YEn4Vbpe December 1st 2021, 8:12pm |
|
@ahighelevation $LPCN FDA grants Fast Track Designation to LPCN 1144 #TRT #hypogonadism - https://t.co/45aF2pSlKu https://t.co/u3rHjWUHhu November 29th 2021, 9:11pm |
|
@Tickeron $LPCN in -5.13% Downtrend, declining for three consecutive days on November 23, 2021. View odds for this and other… https://t.co/e9Cc8p1RXo November 25th 2021, 9:11pm |
|
@Tickeron How will this affect the market? $LPCN entered Uptrend as Momentum indicator ascends above 0 level. #Lipocine… https://t.co/4hkwYpnb1u November 25th 2021, 6:11pm |
|
@Tickeron $LPCN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/fB7TrxZJt8 November 25th 2021, 5:11am |
|
@Tickeron How does this make you feel? $LPCN MACD Histogram turned negative on November 22, 2021. #Lipocine #stockmarket… https://t.co/Mh7AKL4xBa November 24th 2021, 7:11am |
|
@Tickeron $LPCN in +1.7% Uptrend, rising for three consecutive days on November 15, 2021. View odds for this and other indica… https://t.co/3tTqpfPQKe November 23rd 2021, 12:11am |
 |
@pennystocksusa $LPCN 90% chance of approval here imo November 22nd 2021, 5:11pm |
 |
@insidersanalyt1 on 2021-11-18 $LPCN insiders' PURCHASED 25000 securities equal to 0.03% of outstanding shares. Please follow and sh… https://t.co/dlG5ULUPxC November 20th 2021, 5:11pm |
|
@ahighelevation $LPCN Commercialization Partner Secured for the US #TRT #hypogonadism - https://t.co/5X7izY07Kc https://t.co/aImbQvLaSV November 19th 2021, 8:11pm |
 |
@CSIMarket Sales more than Doubled, $LPCN #StockMarket #Lipocine issued Earnings for the period financial report: LPCN announc… https://t.co/0uWa5Pvzjt November 19th 2021, 12:11am |
 |
@InsiderForms $LPCN Insider Patel Mahesh V. has Purchased 25,000 Shares. Title :Director; CEO and President Total Cost: $27,250.0… https://t.co/OkUuNDXjr5 November 19th 2021, 12:11am |
 |
@bkfViking123 RT @EarningsAlley: *INSIDER BUY ALERT* Patel Mahesh V., CEO and President, purchased 25,000 shares of $LPCN at $1.09. Patel Mahesh V. now o… November 19th 2021, 12:11am |
 |
@EarningsAlley *INSIDER BUY ALERT* Patel Mahesh V., CEO and President, purchased 25,000 shares of $LPCN at $1.09. Patel Mahesh V.… https://t.co/x7A0QWnkT4 November 19th 2021, 12:11am |
 |
@fintel_io Insider Patel Mahesh V. reports buying 25,000 shares of $LPCN for a total cost of $27,250.00 https://t.co/ccpk9hkSXv #FNTL November 19th 2021, 12:11am |
 |
@OptionHunt Ticker $LPCN Unusual Volume Detected: 16.97% over average November 18th 2021, 7:11pm |
 |
@TranscriptDaily Lipocine $LPCN Releases Earnings Results https://t.co/M7yunsgP4F November 13th 2021, 5:11am |
 |
@newsfilterio Lipocine Is One To Watch Based On Possible FDA Approval Of TLANDO And NASH Data $ATRS $LPCN https://t.co/bAYZmGa5hp November 12th 2021, 7:11am |
|
@ZacksSmallCap $LPCN: Third Quarter Update - https://t.co/sKb3ygHVc6 by @vanjohn10 https://t.co/2DAF17TIMG November 11th 2021, 8:11pm |
 |
@SteveYonezu $LPCN $6 Price Target out just now, implying 400%+ upside https://t.co/x7btCxszpi November 11th 2021, 8:11pm |
 |
@StckPro $ATRS $LPCN NEW ARTICLE : Lipocine Is One To Watch Based On Possible FDA Approval Of TLANDO And NASH Data… https://t.co/HeLktRjSAV November 11th 2021, 12:11pm |
 |
@SeekingAlpha $LPCN - Lipocine Is One To Watch Based On Possible FDA Approval Of TLANDO And NASH Data. https://t.co/qm1oTwrZYX… https://t.co/FKahxVnqZW November 11th 2021, 12:11pm |
 |
@SmallCapsDaily $LPCN Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2021 PR Newswire… https://t.co/weC4RxcWC8 November 10th 2021, 4:11pm |
 |
@CFinancialNews Lipocine Inc. $LPCN Forecasted to Earn FY2022 Earnings of -$0.06 Per Share https://t.co/V1jDW3W4Q1 #markets November 10th 2021, 2:11pm |
 |
@AmericanBanking Lipocine Inc. $LPCN Forecasted to Earn FY2022 Earnings of -$0.06 Per Share https://t.co/eQI0jECAfN #stocks November 10th 2021, 2:11pm |
 |
@MarketCurrents $LPCN - Lipocine EPS beats by $0.01 https://t.co/PY6VxxPRSM November 10th 2021, 1:11pm |
 |
@investor_feed $LPCN 8-K Lipocine (10 Nov, 8:03am) ? Other Events; Financial Statements and Exhibits https://t.co/SRBnPDL8x3… https://t.co/ZqP7d0zHOF November 10th 2021, 1:11pm |
 |
@StockNewsBot2 $LPCN Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2021 https://t.co/HlHqctNqgD November 10th 2021, 1:11pm |
 |
@stock_titan $LPCN Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2021 https://t.co/Maej5NLgly November 10th 2021, 1:11pm |
|
@investor_feed $LPCN 10-Q Lipocine (10 Nov, 8:00am) ? 2021 Q3 Earnings https://t.co/bZ74FnFMwU #LPCN #10Q #Lipocine #Earnings November 10th 2021, 1:11pm |
 |
@morningdoji $LPCN Nice channel down to support. Positive catalysts in play. Longs will be rewarded soon. https://t.co/6ZRgAuaNsx November 10th 2021, 1:11am |
|
@investor_feed $LPCN 8-K Lipocine (9 Nov, 8:00am) ? Other Events; Financial Statements and Exhibits https://t.co/tPyQh5JAqw… https://t.co/SU1wi7CTwM November 9th 2021, 1:11pm |
|
@Tickeron Lipocine to report earnings on November 10, 2021. Earnings per share (EPS) estimate: $-0.04 $LPCN #Lipocine… https://t.co/wxvPoit8Cd November 9th 2021, 9:11am |
 |
@Leblanc31917509 RT @ZacksSmallCap: $LPCN: Antares Agreement & NASH Fast Track Change The Calculus - https://t.co/uJo14bEJ2U by @vanjohn10 https://t.co/pg2m… November 8th 2021, 9:11pm |
|
@ZacksSmallCap $LPCN: Antares Agreement & NASH Fast Track Change The Calculus - https://t.co/uJo14bEJ2U by @vanjohn10 https://t.co/pg2mWCqh2U November 8th 2021, 6:11pm |
 |
@Johnkak4 RT @bkfViking123: $lpcn fast track ... faster than you think .... March November 7th 2021, 6:11am |
 |
@CrowningProfits Took some $LPCN $ 1.13. November 5th 2021, 5:11pm |
 |
@MaisaCorp $LPCN the U.S. Food and Drug Administration has granted fast-track designation to LPCN 1144 as a treatment for non-… https://t.co/60W4Lf5zO0 November 4th 2021, 11:11pm |
 |
@NameBrandJesus Really like $LPCN https://t.co/BnSpxeOKqz November 4th 2021, 11:11pm |
|
@SmallCapsDaily $LPCN Lipocine Announces FDA Grants Fast Track Designation to LPCN 1144 for Treatment of Non-Cirrhotic NASH PR News… https://t.co/GxZsw5FbVY November 4th 2021, 5:11pm |
 |
@SwingTradeBot Rose Above 50 DMA today: $LPCN ... https://t.co/qwiJH6vr1O November 4th 2021, 3:11pm |
 |
@vanjohn10 $LPCN granted Fast Track Designation for LPCN 1144 as treatment for non-cirrhotic non-alcoholic steatohepatitis (NA… https://t.co/vM5apZLf5S November 4th 2021, 3:11pm |
 |
@TradeWithAlerts A nice print for $LPCN at 11:12am Click https://t.co/KrClvnZuNG for more. Runners ?: https://t.co/VC1LdPHaJR Losers… https://t.co/UfWB7COmoi November 4th 2021, 3:11pm |
|
@bkfViking123 $lpcn fast track ... faster than you think .... March November 4th 2021, 2:11pm |
|
@TradeWithAlerts A nice print for $LPCN at 9:57am Click https://t.co/KrClvnHTp6 for more. Runners ?: https://t.co/VC1LdPYLBp Losers… https://t.co/y5uy4QpiWo November 4th 2021, 1:11pm |
 |
@art_isit $LPCN Announces FDA Grants Fast Track Designation to LPCN 1144 for Treatment of Non-Cirrhotic NASH? November 4th 2021, 1:11pm |
 |
@teslatradeup RT @okayroque: @MrZackMorris $LPCN FDA fast track. Thoughts? November 4th 2021, 1:11pm |
|
@bkfViking123 RT @trade_to_profit: $LPCN news out BRIEF-Lipocine Announces FDA Grants Fast Track Designation To LPCN 1144 for Treatment of Non-Ci... h… November 4th 2021, 1:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?